Information Collection: Medical Use of Byproduct Material, 41070-41071 [2020-14656]

Download as PDF 41070 Federal Register / Vol. 85, No. 131 / Wednesday, July 8, 2020 / Notices V. Conclusion Based on the foregoing considerations, the NRC staff has determined that, pursuant to § 72.7, the exemption is authorized by law, will not endanger life or property or the common defense and security, and is otherwise in the public interest. Therefore, the NRC grants the licensee an exemption from the requirements of § 72.212(a)(2), § 72.212(b)(3), § 72.212(b)(5)(i), § 72.212(b)(11), and § 72.214 only with regard to meeting the requirements of Appendix A, TS A.5.1 and TS A.5.4 of CoC No. 1025. This exemption is effective upon issuance. Dated: July 2, 2020. For the Nuclear Regulatory Commission. John B. McKirgan, Chief, Storage and Transportation Licensing Branch, Division of Fuel Management, Office of Nuclear Material Safety, and Safeguards. [FR Doc. 2020–14651 Filed 7–7–20; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2019–0164] Information Collection: Medical Use of Byproduct Material Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ‘‘Medical Use of Byproduct Material.’’ DATES: Submit comments by August 7, 2020. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:17 Jul 07, 2020 Jkt 250001 Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: routinely edited to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. I. Obtaining Information and Submitting Comments II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35), the NRC recently submitted a request for renewal of an existing collection of information to OMB for review entitled, 10 CFR part 35, ‘‘Medical Use of Byproduct Material.’’ The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on February 26, 2020 (85 FR 11125). 1. The title of the information collection: 10 CFR part 35, ‘‘Medical Use of Byproduct Material.’’ 2. OMB approval number: 3150–0010. 3. Type of submission: Extension. 4. The form number if applicable: Not applicable. 5. How often the collection is required or requested: Reports of medical events, doses to an embryo/fetus or nursing child, or leaking source are reportable on occurrence. A specialty board certifying entity desiring to be recognized by the NRC must submit a one-time request for recognition and infrequently revise the information. 6. Who will be required or asked to respond: Physicians and medical institutions holding an NRC license authorizing the administration of byproduct material or radiation from this material to humans for medical use. A specialty board certification entity desiring to have its certifying process and board certificate recognized by NRC. 7. The estimated number of annual responses: 299,266 (292,182 reporting responses + 7,019 recordkeepers + 65 third party disclosure responses). 8. The estimated number of annual respondents: 7,021 (856 NRC licensees + 6,163 Agreement State licensees + 2 specialty board certification entity). 9. An estimate of the total number of hours needed annually to comply with the information collection requirement or request: 1,166,695 hours (69,391 reporting + 1,097,177 recordkeeping + 127 third party disclosure). 10. Abstract: 10 CFR part 35, ‘‘Medical Use of Byproduct Material,’’ contains NRC’s requirements and provisions for the medical use of byproduct material and for issuance of A. Obtaining Information Please refer to Docket ID NRC–2019– 0164 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2019–0164. A copy of the collection of information and related instructions may be obtained without charge by accessing Docket ID NRC–2019–0164 on this website. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov The supporting statement and burden spreadsheet are available in ADAMS under Accession Nos. ML20128J890 and ML20128J891. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@NRC.GOV. B. Submitting Comments The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your comment submission. All comment submissions are posted at https:// www.regulations.gov and entered into ADAMS. Comment submissions are not routinely edited to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that comment submissions are not PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\08JYN1.SGM 08JYN1 Federal Register / Vol. 85, No. 131 / Wednesday, July 8, 2020 / Notices specific licenses authorizing the medical use of this material. These requirements and provisions provide for the radiation safety of workers, the general public, patients, and human research subjects. Part 35 contains mandatory requirements that apply to NRC licensees authorized to administer byproduct material or radiation to humans for medical use. These requirements also provide voluntary provisions for specialty boards to apply to have their certification processes recognized by the NRC so that their board certified individuals can use the certifications as proof of training and experience. Dated: July 2, 2020. For the Nuclear Regulatory Commission. David C. Cullison, NRC Clearance Officer, Office of the Chief Information Officer. [FR Doc. 2020–14656 Filed 7–7–20; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2020–0159] Design Limits, Loading Combinations, Materials, Construction and Testing of Concrete Containments Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft regulatory guide (DG), DG–1372, ‘‘Design Limits, Loading Combinations, Materials, Construction and Testing of Concrete Containments.’’ This draft guide is proposed Revision 4 of regulatory guide (RG) 1.136 of the same name. It updates the guidance for materials, design, construction, fabrication, examination, and testing of concrete containments in nuclear power plants through endorsement, with exceptions, of the 2019 edition of the American Society of Mechanical Engineers Boiler & Pressure Vessel Code, Section III, Division 2 (American Concrete Institute Standard 359–19), ‘‘Code for Concrete Containments.’’ DATES: Submit comments by September 8, 2020. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. Although a time limit is given, comments and suggestions in connection with items for inclusion in guides currently being developed or jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:17 Jul 07, 2020 Jkt 250001 improvements in all published guides are encouraged at any time. ADDRESSES: You may submit comments by any of the following methods • Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC–2020–0159. Address questions about NRC docket IDs in Regulations.gov to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.Borges@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Office of Administration, Mail Stop: TWFN–7– A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, ATTN: Program Management, Announcements and Editing Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: George Thomas, Office of Nuclear Reactor Regulation, telephone: 301– 415–6181, email: George.Thomas@ nrc.gov; and Edward O’Donnell, Office of Nuclear Regulatory Research, telephone: 301–415–3317, email: Edward.ODonnell@nrc.gov. Both are staff of the U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2020– 0159 when contacting the NRC about the availability of information regarding this action. You may obtain publiclyavailable information related to this action, by any of the following methods: • Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC–2020–0159. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. DG–1372 is available in ADAMS under Accession No. ML20105A215 and the regulatory analysis for DG–1372 is available in PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 41071 ADAMS under Accession No. ML20105A216. B. Submitting Comments Please include Docket ID NRC–2020– 0159 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment submissions at https:// www.regulations.gov as well as enters the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Additional Information The NRC is issuing for public comment a draft guide in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, to explain techniques that the staff uses in evaluating specific issues or postulated events, and to describe information that the staff needs in its review of applications for permits and licenses. The DG, titled ‘‘Design Limits, Loading Combinations, Materials, Construction and Testing of Concrete Containments,’’ is a proposed revision temporarily identified by its task number, DG–1372. It is proposed revision 4 of RG 1.136 of the same name. The guide proposes revised guidance to meet regulatory requirements for materials, design, construction, fabrication, examination, and testing of concrete containments in nuclear power plants. This revision of the guide endorses, with exceptions, the 2019 edition of the American Society of Mechanical Engineers (ASME) Boiler & Pressure Vessel Code (B&PV), Section III, Division 2 (American Concrete Institute Standard 359–19), ‘‘Code for Concrete Containments.’’ This revision of the guide also addresses the acceptability of the Section III Code Cases related to E:\FR\FM\08JYN1.SGM 08JYN1

Agencies

[Federal Register Volume 85, Number 131 (Wednesday, July 8, 2020)]
[Notices]
[Pages 41070-41071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14656]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2019-0164]


Information Collection: Medical Use of Byproduct Material

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a request for renewal of an existing collection of 
information to the Office of Management and Budget (OMB) for review. 
The information collection is entitled, ``Medical Use of Byproduct 
Material.''

DATES: Submit comments by August 7, 2020. Comments received after this 
date will be considered if it is practical to do so, but the Commission 
is able to ensure consideration only for comments received on or before 
this date.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under Review--Open for 
Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, 
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-2084; email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2019-0164 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0164. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2019-0164 on this website.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected] The supporting statement and burden 
spreadsheet are available in ADAMS under Accession Nos. ML20128J890 and 
ML20128J891.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, David Cullison, Office of the 
Chief Information Officer, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2084; email: 
[email protected]

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not want to be publicly 
disclosed in your comment submission. All comment submissions are 
posted at https://www.regulations.gov and entered into ADAMS. Comment 
submissions are not routinely edited to remove identifying or contact 
information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. chapter 35), the NRC recently submitted a request for renewal of 
an existing collection of information to OMB for review entitled, 10 
CFR part 35, ``Medical Use of Byproduct Material.''
    The NRC hereby informs potential respondents that an agency may not 
conduct or sponsor, and that a person is not required to respond to, a 
collection of information unless it displays a currently valid OMB 
control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on February 26, 2020 (85 FR 
11125).
    1. The title of the information collection: 10 CFR part 35, 
``Medical Use of Byproduct Material.''
    2. OMB approval number: 3150-0010.
    3. Type of submission: Extension.
    4. The form number if applicable: Not applicable.
    5. How often the collection is required or requested: Reports of 
medical events, doses to an embryo/fetus or nursing child, or leaking 
source are reportable on occurrence. A specialty board certifying 
entity desiring to be recognized by the NRC must submit a one-time 
request for recognition and infrequently revise the information.
    6. Who will be required or asked to respond: Physicians and medical 
institutions holding an NRC license authorizing the administration of 
byproduct material or radiation from this material to humans for 
medical use. A specialty board certification entity desiring to have 
its certifying process and board certificate recognized by NRC.
    7. The estimated number of annual responses: 299,266 (292,182 
reporting responses + 7,019 recordkeepers + 65 third party disclosure 
responses).
    8. The estimated number of annual respondents: 7,021 (856 NRC 
licensees + 6,163 Agreement State licensees + 2 specialty board 
certification entity).
    9. An estimate of the total number of hours needed annually to 
comply with the information collection requirement or request: 
1,166,695 hours (69,391 reporting + 1,097,177 recordkeeping + 127 third 
party disclosure).
    10. Abstract: 10 CFR part 35, ``Medical Use of Byproduct 
Material,'' contains NRC's requirements and provisions for the medical 
use of byproduct material and for issuance of

[[Page 41071]]

specific licenses authorizing the medical use of this material. These 
requirements and provisions provide for the radiation safety of 
workers, the general public, patients, and human research subjects. 
Part 35 contains mandatory requirements that apply to NRC licensees 
authorized to administer byproduct material or radiation to humans for 
medical use. These requirements also provide voluntary provisions for 
specialty boards to apply to have their certification processes 
recognized by the NRC so that their board certified individuals can use 
the certifications as proof of training and experience.

    Dated: July 2, 2020.

    For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2020-14656 Filed 7-7-20; 8:45 am]
BILLING CODE 7590-01-P